A Retrospective Analysis of Pre Liver Transplant Use of Sorafenib

被引:0
|
作者
Trakroo, Sushrut
Sanaka, Sirish
Jesudoss, Randhir
Al-Osaimi, Abdullah M.
Cohen, Gary S.
Di Carlo, Antonio
Alsabbagh, Mohammed Eyad Yaseen
Qureshi, Kamran
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1862
引用
收藏
页码:S1027 / S1027
页数:1
相关论文
共 50 条
  • [1] Complications Associated With Pre-transplant Use of Sorafenib: Our Experience
    Qureshi, Kamran
    Trakroo, Sushrut
    Di Carlo, Antonio
    Karachristos, Andreas
    Al-Osaimi, Abdullah M. S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S869 - S870
  • [2] Sorafenib Use in the Transplant Setting
    Castelli, Giulia
    Burra, Patrizia
    Giacomin, Anna
    Vitale, Alessandro
    Senzolo, Marco
    Cillo, Umberto
    Farinati, Fabio
    LIVER TRANSPLANTATION, 2014, 20 (09) : 1021 - 1028
  • [3] Pre-transplant utilization of sorafenib is not associated with increased complications after liver transplantation
    Frenette, Catherine T.
    Boktour, Maha
    Burroughs, Sherilyn G.
    Kaseb, Ahmed
    Aloia, Thomas A.
    Galati, Joseph
    Gaber, Ahmed O.
    Monsour, Howard, Jr.
    Ghobrial, Rafik M.
    TRANSPLANT INTERNATIONAL, 2013, 26 (07) : 734 - 739
  • [4] Sorafenib Experience in the Liver Transplant Population
    Cahan, E.
    Gelb, B.
    Mittal, R.
    Morgan, G.
    Goldenberg, A.
    Teperman, L.
    LIVER TRANSPLANTATION, 2013, 19 : S276 - S276
  • [5] INCIDENCE OF PRE-FORMED DONOR SPECIFIC ANTIBODIES AT TIME OF LIVER TRANSPLANT: A RETROSPECTIVE ANALYSIS
    Allyson, Newman
    Michael, Crawford
    Richard, Allen
    Simone, Strasser
    Geoff, Mccaughan
    Nick, Shackel
    Claire, West
    IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (09): : A35 - A35
  • [6] Sorafenib use while waiting for liver transplant: We still need to wait
    Finn, Richard S.
    JOURNAL OF HEPATOLOGY, 2012, 56 (03) : 723 - 725
  • [7] Effect of Pre-Transplant Opioid Use on Post Liver Transplant Outcomes
    Guilbert, K.
    Underwood, H.
    Simon, C. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1117 - 1117
  • [8] Experience with Sorafenib in the Liver Transplant Population.
    Cahan, E.
    Gelb, B.
    Mittal, R.
    Morgan, G.
    Goldenberg, A.
    Teperman, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 245 - 245
  • [9] Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
    Shetty, Kirti
    Dash, Chiranjeev
    Laurin, Jacqueline
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [10] Impact of pre-liver transplant opioid use on post-liver transplant patient outcomes
    Guilbert, K.
    Underwood, H.
    Simon, C. J.
    Cheah, Y. L.
    Akoad, M. E.
    TRANSPLANTATION, 2021, 105 (08) : 142 - 142